How can an independent pharmacy prepare for DSCSA compliance before November 27, 2026?
An independent pharmacy can prepare for DSCSA compliance before the November 27, 2026 small dispenser deadline by focusing on three things at the same time: build simple, repeatable processes; document good-faith effort; and add compliance activities into existing receiving workflow instead of creating a separate operation.
Small dispenser preparation deadline
The smoother approach is gradual operational integration instead of waiting until late 2026 and trying to implement everything at once.
Build simple, repeatable processes
Document good-faith effort
Add compliance into existing receiving workflow
Start gradually. Build defensible habits. Avoid workflow disruption.
For small dispensers, the biggest mistake is waiting until late 2026 and trying to implement everything at once. The smoother approach is gradual operational integration.
Documented processes and interoperability readiness, not perfection.
Under DSCSA, small dispensers with 25 or fewer full-time employees have until November 27, 2026 to meet the enhanced package-level tracing and reconciliation expectations.
FDA guidance and industry practice both emphasize documented processes and interoperability readiness, not perfection.
A practical preparation plan usually starts with supplier visibility, keeps receiving workflow simple, trains staff on exceptions, establishes basic SOPs, builds an inspection-ready documentation habit, prepares suspect and illegitimate product workflows, and uses technology to reduce manual burden.
The operational goal is not “perfect serialization.” The goal is defensible, documented DSCSA process execution aligned with normal pharmacy operations.
A low-disruption DSCSA readiness strategy for independent pharmacies.
DSCSA compliance preparation becomes easier when it is built into what the pharmacy already does every day.
Build simple, repeatable processes
Good DSCSA programs are usually process-driven, not memory-driven. The SOP does not need to be perfect on day one. It needs to exist, be reviewed annually, and match actual workflow.
Document good-faith effort
Advasur guidance consistently treats supplier documentation and onboarding records as inspection-defensible evidence of good-faith effort.
Add compliance into receiving workflow
Add compliance activities into existing receiving workflow instead of creating a separate operation. This staged approach avoids overwhelming technicians and pharmacists during busy dispensing periods.
Seven practical steps before the November 27, 2026 deadline.
The preparation plan below is designed to help independent pharmacies move toward compliance without disrupting daily workflow.
1 — Start with supplier visibility first
Before changing workflow, understand where serialized product data will come from.
- ● Identify all primary wholesalers and direct manufacturers
- ● Confirm which suppliers already send EPCIS data
- ● Document supplier onboarding status
- ● Keep written confirmation when suppliers claim exemptions or delayed onboarding
This reduces confusion later when serialized data starts arriving inconsistently.
2 — Keep receiving workflow simple
Do not try to scan every bottle immediately.
DSCSA does not explicitly require universal scanning of every package. The operational goal is reasonable verification and reconciliation capability.
A low-disruption receiving approach
FDA’s package-level security guidance recognizes that enhanced interoperability and reconciliation are operational processes that evolve across trading partners.
Phase 1
- ● Continue normal receiving
- ● Begin retaining EPCIS and transaction records centrally
- ● Train staff to recognize serialized product identifiers
Phase 2
Add targeted scanning for:
- ● High-risk drugs
- ● Expensive products
- ● Random audit checks
- ● Exception investigation
Phase 3
- ● Expand reconciliation workflows gradually as supplier EPCIS quality improves
3 — Train staff on exceptions, not regulations
Most inspection risk comes from inconsistent handling of exceptions.
Staff do not need to become DSCSA experts. They need to know what missing EPCIS looks like, when to escalate, how to quarantine suspect product, who handles investigations, and where documentation is stored.
4 — Establish basic SOPs now
Independent pharmacies should not wait until 2026 to create SOPs.
- ● Receiving workflow
- ● Supplier verification
- ● Suspect product handling
- ● Reconciliation process
- ● Escalation procedures
- ● Record retention
5 — Build an inspection-ready documentation habit
Inspectors generally look for whether the pharmacy has a reasonable, repeatable process supported by records.
This is often more important than achieving zero discrepancies.
6 — Prepare for suspect and illegitimate product workflows
Every pharmacy should know what happens if product appears counterfeit, diverted, stolen, or otherwise suspicious.
Most pharmacies rarely encounter true illegitimate product situations, but inspectors may ask how the process works.
7 — Use technology to reduce manual burden
The easiest way to avoid workflow disruption is centralization.
Platforms like Advasur 360 are designed to receive and retain EPCIS data, support reconciliation workflows, document exceptions, store records for inspections, and support audit retrieval.
A calm, phased implementation usually performs better operationally than a last-minute aggressive rollout.
Inspection-readiness materials emphasize process over conclusions, documentation over certainty, and escalation over interpretation. That mindset reduces stress during inspections and daily operations.
Recognize exceptions
Staff should know what missing EPCIS looks like and when missing, delayed, or inconsistent transaction data needs to be escalated.
- ● Missing EPCIS
- ● Serialized product identifier issues
- ● Supplier documentation gaps
Escalate clearly
Staff should understand who handles investigations, where documentation is stored, and how exceptions move from receiving to resolution.
- ● When to escalate
- ● Who handles investigations
- ● Where records are stored
Quarantine when needed
Staff should know how to quarantine suspect product and preserve a consistent documentation trail.
- ● Quarantine suspect product
- ● Document findings
- ● Contact supplier
Maintain records that show a reasonable, repeatable process.
Independent pharmacies should maintain inspection-ready documentation as part of routine compliance workflow.
Supplier records
- ● Supplier onboarding records
- ● Primary wholesaler documentation
- ● Direct manufacturer documentation
- ● Written confirmation of exemptions or delayed onboarding
Operational records
- ● EPCIS exceptions
- ● Reconciliation logs
- ● Training records
- ● SOP review history
Investigation records
- ● Investigation documentation
- ● Quarantine documentation
- ● Supplier contact notes
- ● Escalation documentation
The SOP does not need to be perfect on day one. It needs to exist, be reviewed annually, and match actual workflow.
Know what happens when product appears counterfeit, diverted, stolen, or suspicious.
DSCSA requires investigation of suspect product and FDA notification after determination of illegitimacy.
Quarantine product
Separate and secure the product while the issue is reviewed.
Document findings
Record what was found, when it was found, and who reviewed it.
Contact supplier
Work with the supplier to resolve missing, inconsistent, or suspicious product information.
Escalate internally
Follow the pharmacy’s internal escalation procedure for investigation and decision-making.
Retain records
Keep investigation documentation with the rest of the pharmacy’s DSCSA records.
File FDA Form 3911 if illegitimate product is confirmed
If illegitimate product is confirmed, complete the required notification process.
Centralize DSCSA work so compliance does not become a separate operation.
Platforms like Advasur 360 are designed to receive and retain EPCIS data, support reconciliation workflows, document exceptions, store records for inspections, and support audit retrieval.
Receive and retain EPCIS data
Support reconciliation workflows
Document exceptions
Store records for inspections
Support audit retrieval
The operational goal is defensible, documented DSCSA process execution.
The operational goal is not “perfect serialization.” The goal is defensible, documented DSCSA process execution aligned with normal pharmacy operations.
A calm, phased implementation usually performs better operationally than a last-minute aggressive rollout.
The information below reflects Advasur’s understanding of current DSCSA guidance and industry practice. It is provided for general informational purposes. It should not be viewed as legal advice. Dispensers should consult their compliance team or legal counsel for decisions specific to their organization.